Tarek Alhamad, MD, MS, FACP, FASN

Tarek Alhamad, MD, MS, FACP, FASN

Associate Professor of Medicine, Medical Director of Transplant Nephrology, Division of Nephrology

Additional Titles

  • Medical Director, Pancreas Transplant Program
  • Medical Director, Kidney Transplant Program


Patients seen at

Map of location

Center for Advanced Medicine

Mailing Address

Division of Nephrology

  • Mailing Address: 660 S. Euclid Ave., CB 8126
    St. Louis, MO 63110


  • MD: University of Damascus, Damascus, Syria (1999-2005)
  • MS, Public Health Science: Penn State University, Hershey, PA (2010-2013)
  • Residency, Internal Medicine: Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX (2008-2011)
  • Fellowship, General Nephrology: Penn State College of Medicine, Penn State University, Hershey, PA (2011-2013)
  • Fellowship, Transplant Nephrology: Mayo Clinic, Scottsdale, AZ (2013-2014)

Board Certifications

  • Internal Medicine, 2011-2021
  • Nephrology, 2013-2023


Certificate of Merit – American College of Physicians

Research Recognition: Certificate of Excellence
Texas Tech University Health Sciences Center at El Paso, TX
Top Highlighted Posters, US Renal and Urology News
National Kidney Foundation (NKF) Annual Meeting, Las Vegas, NV

Certificate of Excellence, Midwest Young Investigation Forum (YIF), Chicago, IL

Poster of Distinction, American Transplant Congress, Philadelphia, PA

Poster of Distinction, American Transplant Congress, Boston, MA.

Poster of Distinction, American Transplant Congress, Chicago, IL

Clinical Interests

Antibody mediated rejection, simultaneous pancreas and kidney transplantation, high risk kidney transplantation, recurrent glomerulonephritis

Research Interests

  • Acute and chronic rejection
  • Outcomes research in kidney and pancreas transplant
  • Recurrent glomerulonephritis
  • Clinical trials: Dr. Alhamad is the principal investigator of several pharmaceutical clinical trials examining the use of new medications and new diagnostic measures for better surveillance of kidney transplant.
  • Dr. Alhamad is also the site principal investigator of the Clinical Trials in Organ Transplantation (CTOT) from the National Institute of Health (NIH).